Radiologic evaluation of nonseminomatous germ cell tumor of the testis

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations.

ESMO open·2024

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy.

Clinical pharmacology and therapeutics·2016

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer.

Current oncology (Toronto, Ont.)·2014

Cryosurgical ablation for prostate cancer: a current review.

Seminars in urology·1995

Monoclonal antibody imaging of recurrent and metastatic prostate cancer.

Seminars in urology·1995

Traumatic renal artery thrombosis: evaluation and treatment.

Seminars in urology·1995

Indications and techniques for urologic evaluation of the trauma patient with suspected urologic injury.

Seminars in urology·1995

Blunt renal trauma: renal preservation through careful staging and selective surgery.

Seminars in urology·1995

The nonoperative approach to major blunt renal trauma.

Seminars in urology·1995

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Scandinavian journal of immunology·2026

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

Biomarker research·2026

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

Biomarker research·2026

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Leukemia·2026

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

European annals of otorhinolaryngology, head and neck diseases·2026

Related Experiment Videos

Radiologic evaluation of nonseminomatous germ cell tumor of the testis

Related Concept Videos

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations.

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer.

The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy.

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.

Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer.

Cryosurgical ablation for prostate cancer: a current review.

Monoclonal antibody imaging of recurrent and metastatic prostate cancer.

Traumatic renal artery thrombosis: evaluation and treatment.

Indications and techniques for urologic evaluation of the trauma patient with suspected urologic injury.

Blunt renal trauma: renal preservation through careful staging and selective surgery.

The nonoperative approach to major blunt renal trauma.

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

Related Experiment Videos

Radiologic evaluation of nonseminomatous germ cell tumor of the testis

Related Concept Videos

Related Articles